BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20519943)

  • 1. Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes.
    Fuxe J; Vincent T; Garcia de Herreros A
    Cell Cycle; 2010 Jun; 9(12):2363-74. PubMed ID: 20519943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.
    Thuault S; Tan EJ; Peinado H; Cano A; Heldin CH; Moustakas A
    J Biol Chem; 2008 Nov; 283(48):33437-46. PubMed ID: 18832382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
    Saitoh M
    Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer.
    Liu X; Yun F; Shi L; Li ZH; Luo NR; Jia YF
    Asian Pac J Cancer Prev; 2015; 16(15):6201-6. PubMed ID: 26434817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.
    Su J; Morgani SM; David CJ; Wang Q; Er EE; Huang YH; Basnet H; Zou Y; Shu W; Soni RK; Hendrickson RC; Hadjantonakis AK; Massagué J
    Nature; 2020 Jan; 577(7791):566-571. PubMed ID: 31915377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
    Katsuno Y; Lamouille S; Derynck R
    Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between TGF-β/SMAD and BMP/SMAD signaling pathways in the epithelial mesenchymal transition of A549 cells induced by silica.
    Yu Y; Lin Y; Yang G; Tian L
    Toxicol Mech Methods; 2018 May; 28(4):286-292. PubMed ID: 29161937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β Signaling in Cancer.
    Syed V
    J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing in EMT and TGF-β signaling during cancer progression.
    Zhang YE; Stuelten CH
    Semin Cancer Biol; 2024 Jun; 101():1-11. PubMed ID: 38614376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer.
    Miyazono K
    Proc Jpn Acad Ser B Phys Biol Sci; 2009; 85(8):314-23. PubMed ID: 19838011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
    Guo Y; Cui W; Pei Y; Xu D
    Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of the TGF-β Paradox to EMT-MET programs.
    Morrison CD; Parvani JG; Schiemann WP
    Cancer Lett; 2013 Nov; 341(1):30-40. PubMed ID: 23474494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
    Espinoza I; Miele L
    Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.